Drawing for MIRAVANT MEDICAL TECHNOLOGIES

USPTO serial 76300325

MIRAVANT MEDICAL TECHNOLOGIES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MICHOS, JOHN E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MIRAVANT MEDICAL TECHNOLOGIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert G. Lancaster

ROBERT G LANCASTER BRYAN CAVE LLP211 N BROADWAY STE 3600ST LOUIS, MO 63102-2733UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations using photodynamic therapy for detecting cancer and lesions, and for use in the treatment and diagnosis of diseases relating to oncology, ophthalmology, urology, dermatology, gynecology, cardiology and immunology (immune therapy)ACTIVE—
010Medical and ophthalmology devices and equipment used in photodynamic therapy, namely light production and light-delivery devices and accessories therefor, namely, lasers, semiconductor diode light sources, lamps, fiber optics devices, channels, lenses, microlenses, waveguides, diffusion devices, catheter devices, and devices for cutaneous application of pharmaceuticals, sold emptyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 8, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 21, 2005EX5GSOU EXTENSION 5 GRANTED—
Oct 3, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2005EXT5SOU EXTENSION 5 FILED—
May 3, 2005EX4GSOU EXTENSION 4 GRANTED—
Apr 4, 2005MAILPAPER RECEIVED—
Apr 1, 2005EXT4SOU EXTENSION 4 FILED—
Nov 3, 2004EX3GSOU EXTENSION 3 GRANTED—
Oct 12, 2004MAILPAPER RECEIVED—
Sep 30, 2004EXT3SOU EXTENSION 3 FILED—
Apr 16, 2004CFITCASE FILE IN TICRS—
Apr 5, 2004MAILPAPER RECEIVED—
Apr 1, 2004EX2GSOU EXTENSION 2 GRANTED—
Apr 1, 2004EXT2SOU EXTENSION 2 FILED—
Nov 5, 2003EX1GSOU EXTENSION 1 GRANTED—
Oct 6, 2003MAILPAPER RECEIVED—
Oct 1, 2003EXT1SOU EXTENSION 1 FILED—
Apr 1, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 7, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2002NPUBNOTICE OF PUBLICATION—
Oct 30, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 23, 2002CNEAEXAMINERS AMENDMENT MAILED—
Sep 16, 2002PETGPETITION TO REVIVE-GRANTED—
Jun 13, 2002PETRPETITION TO REVIVE-RECEIVED—
May 29, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 27, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2001DOCKASSIGNED TO EXAMINER—
Sep 20, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance